Frequent blackouts aren't just engineering failures. They are the cost of a bureaucratic monologue that treats energy ...
The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...
Since AI has become a powerful trend in the field of technology, it is natural for potential developers to wonder whether ...
Following storms Thursday, RG&E and NYSEG said Friday morning they were near full restoration for outages that impacted some ...
Fujitsu Limited and IBM Japan, Ltd. today announced that they will accelerate their collaboration in the field of business system modernization in order to advance enterprise digital transformation ...
Antares Mark-0 Becomes First Advanced Nuclear Reactor to Achieve Criticality Under DOE Pilot Program
Antares Nuclear Inc.’s Mark-0—a sodium heat-pipe-cooled microreactor fueled by high-assay low-enriched uranium (HALEU) tri-structural isotropic (TRISO) fuel compacts—has achieved zero-power ...
Stainless, a New York-based startup, founded in 2022, rose to prominence in the emerging AI industry for automating the creation and maintenance of software development kits, or SDKs — the libraries ...
On March 19, 2026, FERC approved Southwest Power Pool, Inc.’s (SPP) System Support Resource (SSR) program to allow SPP, under specified conditions, to keep certain generating units that plan to retire ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
March 10 (Reuters) - OpenAI plans to soon launch its AI video generator Sora in ChatGPT, The Information reported on Tuesday, citing people familiar with the matter. Sign up here. While text-centric ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results